Treatment of bacterial infections in pregnancy.
Treatment of bacterial infections in pregnancy requires an understanding of the unique problems related to the administration of antibacterial agents to pregnant women. The clinician must be aware not only of the antibiotic-associated untoward effects which may develop in the mother, but also of the possibility that adverse reactions may occur in the fetus. Precise knowledge of the microbial aetiology of those infections which occur during pregnancy and an understanding of the intricacies of antibiotic administration to pregnant women will assure the greatest likelihood that bacterial infections in pregnancy will be effectively, and safely, treated.
D000031:Abortion, Septic / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001437:Bacteriuria / Q000188:drug therapy; D003428:Cross Infection / Q000188:drug therapy; D005260:Female; D005333:Fetus / Q000502:physiology; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D011014:Pneumonia / Q000188:drug therapy / Q000382:microbiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000503:physiopathology; D011704:Pyelonephritis / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013587:Syphilis / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents